Coherus Oncology, Inc 10-Q for FY2025 Q2
Coherus Oncology, Inc. (CHRS)
10-Q
2025-08-07
For: 2025-06-30
View Original
Added on
April 09, 2026
About this 10-Q
Coherus Oncology, Inc filed this 10-Q on August 7, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).
Headline figures
Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $10.25M
- down 0.4% from $10.3M a year earlier
- Net income
- $297.77M
- compared with a net loss of $12.92M a year earlier
- Diluted EPS
- $2.57
- compared with -$0.11 a year earlier